LBF18107PG01
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1821 |
LipidMaps | LMFA03010089 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF18107PG01 |
2,3-dinor-6-keto Prostaglandin F1α | |
---|---|
Structural Information | |
5- [ (3R,5S) -Dihydroxy-2R- (3S-hydroxy-trans-1-octenyl) cyclopentan-1R-yl ] -4-oxopentanoic acid | |
| |
2,3-DINOR-6-KETO-PGF1 alpha | |
Formula | C18H30O6 |
Exact Mass | 342.204238692 |
Average Mass | 342.42719999999997 |
SMILES | [C@@H]([C@@H](CC(=O)CCC(O)=O)1)(C=C[C@H](O)CCCCC)[C@H](O)C[C@@H]1O |
Physicochemical Information | |
[ α ]20.2 D = +16.9° (C=1.76 CHLOROFORM, measured after 24 hours at 20°C) | |
METHANOL Pace-Asciak_CR et al. | |
When prostaglandin I2 or its non-enzymatic degradation product (6-keto-prostaglandin F1 alpha ) was infused into man, a major urinary metbolite was 2,3-dinor-6-keto-prostaglandin F1 alpha , a beta -oxidation product Needleman_P et al.. | |
Spectral Information | |
Mass Spectra | METHOXIME TRI-TMS ETHER METHYL ESTER ; m/e 601(M+), 586, 570, 530, 511, 496, 480, 440, 421, 390, 350, 300, 294, 263, 217, 205, 191, 73 Pace-Asciak_CR et al. |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|